Has Jaime Kenny, OD received payments from drug or device companies?

Yes. Drug and device makers reported $3,853 in general payments to Jaime Kenny, OD across 83 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jaime Kenny, OD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jaime Kenny, OD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jaime Kenny, OD

Optometrist · Webster, NYNPI 1154368736

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,010 of the $3,853 with a category attached, or 78.1%. 18 manufacturers reported payments, led by AstraZeneca at 30.6% of the total. 2025 is the largest year on record at $1,903, more than ten times the $112 reported in 2019. Among optometrist clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,853in general payments, 2019–2025

Across 83 payments — averaging $46.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1K
Tarsus Pharmaceuticals, Inc.$395
Glaukos Corporation$312
Sun Pharmaceutical Industries Inc.$297
AbbVie$261
Sight Sciences, Inc.$249
plus $1K from 12 others

What the payments were for

Travel & lodging$84322%
Food & beverage$3,01078%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	9	$1,178
Tarsus Pharmaceuticals, Inc.	14	$395
Glaukos Corporation	4	$312
Sun Pharmaceutical Industries Inc.	6	$297
AbbVie(2 entities)	7	$261
Sight Sciences, Inc.	3	$249
Bausch & Lomb Americas Inc.	7	$192
Alcon	10	$190
Biotissue Holdings Inc.	2	$185
Oyster Point Pharma, Inc.	7	$138
Amgen	1	$125
LKC Technologies, Inc.	1	$122
Johnson & Johnson Surgical Vision, Inc.	3	$53
Dompe US, Inc.	3	$50
Coopervision Inc.	2	$39
Harrow Eye, LLC	2	$31
Rayner Intraocular Lenses Limited	1	$19
Johnson & Johnson Vision Care, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,853 in reported general payments places this provider in the 90th percentile of 2,743 optometrist providers in New York.

See all optometrist providers in New York →

Medicare billing

Part B allowed, 2024

$14,021

Medicare patients

Services billed

150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Latanoprost	135	$1,607
Prednisolone Acetate	38	$1,446
Timolol Maleate	28	$1,323
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	52	$664
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	38	$658
Acyclovir	12	$39

Paid to pharmacies, not to this prescriber.

Other optometrist in Webster

Shari GustinWebster$9K
Roy KlineLake Katrine$822K
Susan ResnickNew York$463K
Murray FingeretHewlett$374K
Albert MorierSlingerlands$347K
Denise WhittamNew York$343K
Justin BazanBrooklyn$303K
Jennifer TsaiNew York$275K
Alexander KabiriQueens Village$268K
Sophia VisanjiNew York$233K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →